Real World Survay of Atrial Fibrillation Patients Treated with Warfarine and Non-vitamin K Antagonist Oral Anticoaglants: SAKURA AF REGISTRY

Real World Survay of Atrial Fibrillation Patients Treated with Warfarine and Non-vitamin K Antagonist Oral Anticoaglants: SAKURA AF REGISTRY - Multicenter Registry Study of Atrial Fibrillation Patients

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000014420

Enrollment

5000

Registered

2014-09-18

Start date

2013-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial Fibrillation

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Atrial fibrillation patients aged 20 years or older attending clinic or hospital treated by warfarin or non-vitamin K oral anticoaglants

Exclusion criteria

Exclusion criteria: 1) Patients with absolute contraindications to anticoaglants 2) Patients with severe liver disease, kidney disease, blood disorders, lung disease, etc. 3) Pregnant women, breastfeeding women, possibly pregnant women 4) Patient administrated with HIV protease inhibitor (ritonavir, atazanavir, indinavir, etc.) 5) Patients administered with azole antifungal agents (except fluconazole, itraconazole, voriconazole, ketoconazole, etc.) 6) Other, inappropriate patients judged by research doctor or research investigator

Design outcomes

Primary

Measure	Time frame
Effictiveness: ischemic stroke or non-central nervous system systemic embolism Safety: Major bleeding events	—

Secondary

Measure	Time frame
Effectiveness: stroke, ischemic stroke, hemorrhagic stroke, systemic embolism, acute myocardial infarction, unstable angina, cardiovascular death, deep vein thrombosis, pulmonary embolism chapter, transient ischemic attack Safety: non-major bleeding events	—

Countries

Japan

Contacts

Public ContactYukimi Kokubun

RPM Co.,Ltd. SAKURA AF registry secretariat

sakura@rpmedical.co.jp03-5325-5821

Outcome results